1. Adaptation of remote symptom monitoring using electronic patient-reported outcomes for implementation in real-world settings. Issue 28 (1st October 2022) Authors: Dent, D'Ambra; Ingram, Stacey A.; Caston, Nicole E.; Thigpen, Haley; Lalor, Fallon; Jamy, Omer; Giri, Smith; Azuero, Andres; Young Pierce, Jennifer; McGowen, Chelsea L.; Daniel, Casey L.; Andrews, Courtney J.; Huang, Chao-Hui; Dionne-Odom, James Nicholas; Weiner, Bryan J; Howell, Doris; Jackson, ... Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents. Issue 13 (10th November 2022) Authors: Zainaldin, Carl; Arora, Sankalp; Bathini, Srilakshmi; Gupta, Udita; Pandya, Vishruti; Bae, Sejong; Worth, Sarah; Bachiashvili, Kimo; Bhatia, Ravi; Godby, Kelly; Jamy, Omer; Rangaraju, Sravanti; Diamond, Barry; Oliver, Josh D.; Salzman, Donna; Di Stasi, Antonio; Vachhani, Pankit Journal: Leukemia & lymphoma Issue: Volume 63:Issue 13(2022) Page Start: 3245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Emerging first line treatment options for bladder cancer: a review of phase II and III therapies in the pipeline. (2nd October 2017) Authors: Jamy, Omer; Sonpavde, Guru Journal: Expert opinion on emerging drugs Issue: Volume 22:Number 4(2017:Dec.) Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First report of novel heterozygous WRAP53 p.Ala522Glyfs*8 mutation associated dyskeratosis congenita. (14th October 2021) Authors: Magnusson, Tylan; Godby, Richard C.; Bachiashvili, Kimo; Jamy, Omer Journal: British journal of haematology Issue: Volume 196:Number 4(2022) Page Start: e27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Genomic alterations in neuroendocrine cancers of the ovary. Issue 1 (December 2016) Authors: Yaghmour, George; Prouet, Philippe; Wiedower, Eric; Jamy, Omer; Feldman, Rebecca; Chandler, Jason; Pandey, Manjari; Martin, Mike Journal: Journal of ovarian research Issue: Volume 9:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Hypomethylating agent/venetoclax versus intensive chemotherapy in adults with relapsed or refractory acute myeloid leukaemia. (4th May 2022) Authors: Jamy, Omer; Lin, Karen; Worth, Sarah; Bachiashvili, Kimo; Rangaraju, Sravanti; Vachhani, Pankit; Bhatia, Ravi Journal: British journal of haematology Issue: Volume 198:Number 3(2022) Page Start: e35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Outcomes of fludarabine, high dose cytarabine and granulocyte-colony stimulating factor (FLAG) as re-induction for residual acute myeloid leukemia on day 14 bone marrow. (November 2018) Authors: Jamy, Omer; Bae, Sejong; Costa, Luciano J.; Erba, Harry P.; Papadantonakis, Nikolaos Journal: Leukemia research Issue: Volume 74(2018) Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase II clinical trial of one dose of post‐transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched‐unrelated donor transplantation. Issue 10 (31st July 2021) Authors: Jamy, Omer; Innis‐Shelton, Raquel; Bal, Susan; Paluri, Ravi; Salzman, Donna; Di Stasi, Antonio; Costa, Luciano; Meredith, Ruby; Lamb, Lawrence; Minagawa, Kentaro; Mineishi, Shin; Saad, Ayman Journal: American journal of hematology Issue: Volume 96:Issue 10(2021) Page Start: E396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Retracted: First report of novel heterozygous WRAP53 p.Ala522Glyfs*8 mutation associated dyskeratosis congenita. (14th October 2021) Authors: Magnusson, Tylan; Godby, Richard C.; Bachiashvili, Kimo; Jamy, Omer Journal: British journal of haematology Issue: Volume 196:Number 4(2022) Page Start: e27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Risk and outcomes of second malignant neoplasms in chronic myeloid leukemia survivors. (July 2019) Authors: Jamy, Omer; Sarmad, Rehan; Costa, Luciano Journal: Leukemia research Issue: Volume 82(2019) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗